These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16720930)

  • 21. [Clinical analysis of 59 cases of primary gastric non-Hodgkin's lymphoma].
    He YF; Li YH; Huang HQ; Xia ZJ; Sun XF; Lin TY; Lin XB; Yuan ZY; Li ZM; Wang FH; Wang SS; Jiang WQ
    Ai Zheng; 2005 Apr; 24(4):475-7. PubMed ID: 15820073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
    Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
    Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract.
    Kim SJ; Kim BS; Choi CW; Seo HY; Seol HR; Sung HJ; Kim IS; Kim CY; Jung KY; Kim JS
    Leuk Lymphoma; 2006 Jul; 47(7):1265-73. PubMed ID: 16923556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression.
    Hammel P; Haioun C; Chaumette MT; Gaulard P; Divine M; Reyes F; Delchier JC
    J Clin Oncol; 1995 Oct; 13(10):2524-9. PubMed ID: 7595703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.
    Reyes F; Lepage E; Ganem G; Molina TJ; Brice P; Coiffier B; Morel P; Ferme C; Bosly A; Lederlin P; Laurent G; Tilly H;
    N Engl J Med; 2005 Mar; 352(12):1197-205. PubMed ID: 15788496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome of primary gastric lymphoma treated with chemotherapy alone or surgery followed by chemotherapy.
    Chang MC; Huang MJ; Su YW; Chang YF; Lin J; Hsieh RK
    J Formos Med Assoc; 2006 Mar; 105(3):194-202. PubMed ID: 16520834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.
    Pinnix CC; Gunther JR; Milgrom SA; Cruz Chamorro RJ; Medeiros LJ; Khoury JD; Amini B; Neelapu S; Lee HJ; Westin J; Fowler N; Nastoupil L; Dabaja B
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):447-455. PubMed ID: 30769175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy is an effective first line treatment for early stage gastric mucosa-associated lymphoid tissue lymphoma.
    Yoon SS; Hochberg EP
    Cancer Treat Rev; 2006 Apr; 32(2):139-43. PubMed ID: 16524666
    [No Abstract]   [Full Text] [Related]  

  • 29. Bilateral, primary, low-grade, diffuse B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) of the breast.
    Zobolas B; Sakorafas GH; Kourakli I; Tsiotou AG
    Breast J; 2002; 8(6):382. PubMed ID: 12390362
    [No Abstract]   [Full Text] [Related]  

  • 30. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.
    Martelli M; Vignetti M; Zinzani PL; Gherlinzoni F; Meloni G; Fiacchini M; De Sanctis V; Papa G; Martelli MF; Calabresi F; Tura S; Mandelli F
    J Clin Oncol; 1996 Feb; 14(2):534-42. PubMed ID: 8636768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
    Federico M; Clò V; Brugiatelli M; Carotenuto M; Gobbi PG; Vallisa D; Lombardo M; Avanzini P; Di Renzo N; Dini D; Baldini L; Silingardi V
    Haematologica; 1998 Sep; 83(9):800-11. PubMed ID: 9825577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
    Unterhalt M; Herrmann R; Tiemann M; Parwaresch R; Stein H; Trümper L; Nahler M; Reuss-Borst M; Tirier C; Neubauer A; Freund M; Kreuser ED; Dietzfelbinger H; Bodenstein H; Engert A; Stauder R; Eimermacher H; Landys K; Hiddemann W
    Leukemia; 1996 May; 10(5):836-43. PubMed ID: 8656680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma).
    Son SH; Choi BO; Kim GW; Yang SW; Hong YS; Choi IB; Kim YS
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):86-91. PubMed ID: 19632068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rituximab as consolidation therapy did not improve outcome in patients with diffuse large B-cell lymphoma at complete response after dose-dense chemotherapy (CHOP-14).
    Avilès A; Nambo MJ; Huerta-Guzmàn J; Silva L; Neri N
    Cancer Biother Radiopharm; 2015 Apr; 30(3):107-10. PubMed ID: 25871407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
    Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
    Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma.
    Maor MH; Velasquez WS; Fuller LM; Silvermintz KB
    J Clin Oncol; 1990 Feb; 8(2):266-71. PubMed ID: 1688927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
    Zinzani PL; Stefoni V; Musuraca G; Tani M; Alinari L; Gabriele A; Marchi E; Pileri S; Baccarani M
    Cancer; 2004 May; 100(10):2190-4. PubMed ID: 15139063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma.
    Raderer M; Wohrer S; Streubel B; Drach J; Jager U; Turetschek K; Troch M; Puspok A; Zielinski CC; Chott A
    Oncology; 2006; 70(6):411-7. PubMed ID: 17220639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial.
    Advani RH; Ansell SM; Lechowicz MJ; Beaven AW; Loberiza F; Carson KR; Evens AM; Foss F; Horwitz S; Pro B; Pinter-Brown LC; Smith SM; Shustov AR; Savage KJ; Vose JM
    Br J Haematol; 2016 Feb; 172(4):535-44. PubMed ID: 26627450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy versus combined therapy in early stages with bulky disease aggressive malignant lymphoma.
    Avilés A; Fernández R; Calva A; Neri N; Huerta-Guzmán J; Nambo MJ
    Hematology; 2003 Feb; 8(1):7-10. PubMed ID: 12623421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.